Organon Net Income Applicable To Common Shares from 2010 to 2026

OGN Stock  USD 8.10  0.19  2.29%   
Organon Net Income Applicable To Common Shares yearly trend continues to be very stable with very little volatility. Net Income Applicable To Common Shares is likely to grow to about 1.3 B this year. Net Income Applicable To Common Shares is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Income Applicable To Common Shares  
First Reported
2020-03-31
Previous Quarter
145 M
Current Value
160 M
Quarterly Volatility
173.9 M
 
Covid
 
Interest Hikes
Check Organon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organon's main balance sheet or income statement drivers, such as Depreciation And Amortization of 236.8 M, Interest Expense of 627.9 M or Selling General Administrative of 1.2 B, as well as many indicators such as Price To Sales Ratio of 1.05, Dividend Yield of 0.0434 or PTB Ratio of 9.81. Organon financial statements analysis is a perfect complement when working with Organon Valuation or Volatility modules.
  
Build AI portfolio with Organon Stock
Check out the analysis of Organon Correlation against competitors.
Evaluating Organon's Net Income Applicable To Common Shares across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Organon Co's fundamental strength.

Latest Organon's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Organon Co over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Organon's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organon's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Organon Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean1,660,017,647
Geometric Mean1,559,189,050
Coefficient Of Variation35.77
Mean Deviation432,800,692
Median1,801,000,000
Standard Deviation593,817,809
Sample Variance352619.6T
Range2.4B
R-Value(0.48)
Mean Square Error289349.6T
R-Squared0.23
Significance0.05
Slope(56,483,333)
Total Sum of Squares5641913.4T

Organon Net Income Applicable To Common Shares History

20261.3 B
2025777.6 M
2024864 M
2023B
2022917 M
20211.4 B
20202.2 B

About Organon Financial Statements

Organon investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Organon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Income Applicable To Common Shares777.6 M1.3 B

Pair Trading with Organon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.

Moving together with Organon Stock

  0.64JNJ Johnson JohnsonPairCorr
  0.83LPCN LipocinePairCorr

Moving against Organon Stock

  0.82HPQ HP IncPairCorr
  0.59MSFT MicrosoftPairCorr
  0.43BRK-A Berkshire HathawayPairCorr
  0.32IBM International BusinessPairCorr
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
Check out the analysis of Organon Correlation against competitors.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Will Pharmaceuticals sector continue expanding? Could Organon diversify its offerings? Factors like these will boost the valuation of Organon. Anticipated expansion of Organon directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Organon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.56)
Dividend Share
0.6
Earnings Share
1.98
Revenue Per Share
24.34
Quarterly Revenue Growth
0.013
Investors evaluate Organon using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organon's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organon's market price to deviate significantly from intrinsic value.
It's important to distinguish between Organon's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organon should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organon's market price signifies the transaction level at which participants voluntarily complete trades.